943130-41-4

Upstream product

• 698-16-8 benzohydroximoyl chloride 
• 123844-20-2 ethyl 3-cyclopropylprop-2-ynoate 
• 24922-02-9 Ethyl 3-cyclopropyl-3-oxopropionate 
• 932-90-1 Benzaldoxime 
• 100-52-7 benzaldehyde 

Downstream Products

• 943130-42-5 5-cyclopropyl-3-phenyl-1,2-oxazole-4-carboxylic acid 

Relevant academic research and scientific papers

ISOXAZOLYL-CARBONYLOXY AZABICYCLO[3.2.1]OCTANYL COMPOUNDS AS FXR ACTIVATORS

The disclosure relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): wherein L1, L2, A, B, R1, R2, R3, and R4 are described herein.

ARYL-ISOXAZOLO-4-YL-OXADIAZOLE DERIVATIVES

The present invention is concerned with isoxazol-4-yl-oxadiazole derivatives of formula (I) wherein R1 is hydrogen, halogen, aryl, heterocyclyl, heteroaryl, cyano, lower alkyl, -(CH2)n-cycloalkyl, -(CH2)n/

Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives

The present invention is concerned with aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives of formula I: wherein R1 to R5 are as defined in the specification and pharmaceutically acceptable acid addition salts thereof. This class

Aryl-isoxazol-4-yl-imidazole derivatives

The present invention is concerned with aryl-isoxazol-4-yl-imidazole derivatives of formula I: wherein R1 to R6 are as defmed in the specification and pharmaceutically acceptable acid addition salts thereof. This class of compounds h